Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
43.55
-0.13 (-0.30%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Nanobiotix Employees
Nanobiotix had 100 employees as of December 31, 2025. The number of employees decreased by 8 or -7.41% compared to the previous year.
Employees
100
Change (1Y)
-8
Growth (1Y)
-7.41%
Revenue / Employee
$382,682
Profits / Employee
-$281,331
Market Cap
2.25B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 100 | -8 | -7.41% | 100 | 0 |
| Dec 31, 2024 | 108 | 6 | 5.88% | 108 | 0 |
| Dec 31, 2023 | 102 | 0 | - | 102 | 0 |
| Dec 31, 2022 | 102 | 2 | 2.00% | 102 | 0 |
| Dec 31, 2021 | 100 | 10 | 11.11% | 100 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Agios Pharmaceuticals | 540 |
| Biohaven | 274 |
| Xencor | 260 |
| Kardigan | 241 |
| Stoke Therapeutics | 170 |
| Zenas BioPharma | 167 |
| Aurinia Pharmaceuticals | 128 |
NBTX News
- 22 days ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 2 months ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 2 months ago - Nanobiotix Reports Q1 2026 Update; Expects Cash Runway Through 2029 - Nasdaq
- 2 months ago - Nanobiotix Provides First Quarter 2026 Operational and Financial Update - GlobeNewsWire
- 2 months ago - Nanobiotix Earnings release: Q1 2026 - Filings
- 2 months ago - Nanobiotix Joins the Euronext Tech Leaders Index - GlobeNewsWire
- 3 months ago - NANOBIOTIX Announces Closing of Global Offering - GlobeNewsWire
- 3 months ago - Nanobiotix Exercises Underwriters' Option In Global Offering, Gross Proceeds Reach $100 Mln - Nasdaq